As of 2026-03-25, the Relative Valuation of Biosynex SA (ALBIO.PA) is (49.69) EUR. This relative valuation is based on P/E multiples. With the latest stock price at 0.85 EUR, the upside of Biosynex SA based on Relative Valuation is -5946.1%.
The range of the Relative Valuation is (40.74) - (58.15) EUR.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 10.8x - 16.1x | 13.4x |
| Forward P/E multiples | 10.2x - 15.4x | 12.8x |
| Fair Price | (40.74) - (58.15) | (49.69) |
| Upside | -4892.7% - -6941.6% | -5946.1% |
| Date | P/E |
| 2026-03-24 | -0.22 |
| 2026-03-23 | -0.22 |
| 2026-03-20 | -0.22 |
| 2026-03-19 | -0.22 |
| 2026-03-18 | -0.22 |
| 2026-03-17 | -0.22 |
| 2026-03-16 | -0.22 |
| 2026-03-13 | -0.23 |
| 2026-03-12 | -0.23 |
| 2026-03-11 | -0.23 |
| 2026-03-10 | -0.23 |
| 2026-03-09 | -0.23 |
| 2026-03-06 | -0.24 |
| 2026-03-05 | -0.23 |
| 2026-03-04 | -0.23 |
| 2026-03-03 | -0.22 |
| 2026-03-02 | -0.25 |
| 2026-02-27 | -0.25 |
| 2026-02-26 | -0.25 |
| 2026-02-25 | -0.26 |
| 2026-02-24 | -0.25 |
| 2026-02-23 | -0.26 |
| 2026-02-20 | -0.26 |
| 2026-02-19 | -0.26 |
| 2026-02-18 | -0.24 |
| 2026-02-17 | -0.26 |
| 2026-02-16 | -0.27 |
| 2026-02-13 | -0.27 |
| 2026-02-12 | -0.27 |
| 2026-02-11 | -0.27 |
| 2026-02-10 | -0.27 |
| 2026-02-09 | -0.27 |
| 2026-02-06 | -0.27 |
| 2026-02-05 | -0.25 |
| 2026-02-04 | -0.24 |
| 2026-02-03 | -0.25 |
| 2026-02-02 | -0.25 |
| 2026-01-30 | -0.26 |
| 2026-01-29 | -0.28 |
| 2026-01-28 | -0.25 |
| 2026-01-27 | -0.27 |
| 2026-01-26 | -0.30 |
| 2026-01-23 | -0.23 |
| 2026-01-22 | -0.20 |
| 2026-01-21 | -0.19 |
| 2026-01-20 | -0.20 |
| 2026-01-19 | -0.19 |
| 2026-01-16 | -0.19 |
| 2026-01-15 | -0.19 |
| 2026-01-14 | -0.19 |